RAUDENSKÁ, Martina, Jaromír GUMULEC, Jan BALVAN and Michal MASAŘÍK. Caveolin-1 in oncogenic metabolic symbiosis. International journal of cancer. HOBOKEN: International Union Against Cancer, 2020, vol. 147, No 7, p. 1793-1807. ISSN 0020-7136. Available from: https://dx.doi.org/10.1002/ijc.32987.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Caveolin-1 in oncogenic metabolic symbiosis
Authors RAUDENSKÁ, Martina (203 Czech Republic, belonging to the institution), Jaromír GUMULEC (203 Czech Republic, belonging to the institution), Jan BALVAN (203 Czech Republic, belonging to the institution) and Michal MASAŘÍK (203 Czech Republic, guarantor, belonging to the institution).
Edition International journal of cancer, HOBOKEN, International Union Against Cancer, 2020, 0020-7136.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 7.396
RIV identification code RIV/00216224:14110/20:00114233
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1002/ijc.32987
UT WoS 000527026700001
Keywords in English Caveolin-1; metabolic symbiosis; tumor microenvironment; cancer; metabolism; glycolysis; cancer-associated fibroblast
Tags 14110515, 14110518, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 29/10/2020 13:07.
Abstract
Metabolic phenotypes of cancer cells are heterogeneous and flexible as a tumor mass is a hurriedly evolving system capable of constant adaptation to oxygen and nutrient availability. The exact type of cancer metabolism arises from the combined effects of factors intrinsic to the cancer cells and factors proposed by the tumor microenvironment. As a result, a condition termed oncogenic metabolic symbiosis in which components of the tumor microenvironment (TME) promote tumor growth often occurs. Understanding how oncogenic metabolic symbiosis emerges and evolves is crucial for perceiving tumorigenesis. The process by which tumor cells reprogram their TME involves many mechanisms, including changes in intercellular communication, alterations in metabolic phenotypes of TME cells, and rearrangement of the extracellular matrix. It is possible that one molecule with a pleiotropic effect such as Caveolin-1 may affect many of these pathways. Here, we discuss the significance of Caveolin-1 in establishing metabolic symbiosis in TME.
Links
GA18-03978S, research and development projectName: Efekt buněčné tuhosti a mikroprostředí jako prediktor odpovědi na léčbu karcinomů hlavy a krku
Investor: Czech Science Foundation
NV18-08-00229, research and development projectName: Interakce buněk nádorového mikroprostředí jako nový nástroj predikce účinnosti terapie nádorů hlavy a krku
Investor: Ministry of Health of the CR
PrintDisplayed: 13/7/2024 17:12